-
Recent Posts
Archives
- March 2023
- November 2021
- December 2020
- November 2020
- March 2020
- December 2019
- November 2019
- September 2019
- July 2019
- February 2019
- September 2017
- November 2016
- September 2016
- June 2016
- May 2016
- March 2016
- October 2015
- August 2015
- May 2015
- July 2014
- June 2014
- April 2013
- March 2013
- February 2013
- January 2013
Categories
Meta
Tag Archives: L-DOPA
Inhaled Levodopa
Introduction Levodopa was the first main, and arguably still the best, treatment for Parkinson’s disease. Being similar in structure to tyrosine, it is absorbed through the gut by an amino acid transporter – its half life in the blood is … Continue reading
Posted in Parkinson's Disease, Uncategorized
Tagged inhaled levodopa, L-DOPA, Parkinson Disease
Leave a comment
Double-Blind Double-Dummy Randomised Study of Continuous Intrajejunal infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease
Background Levodopa, a pro-drug of dopamine, has been used successfully to treat symptoms of Parkinson’s disease for fifty years and remains the mainstay of medical management. However after years of treatment, with increasing loss of dopaminergic presynaptic terminals, symptomatic control … Continue reading
Journal Club Review: A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease
Summary for General Readers Given it was first introduced to treat Parkinson’s disease in the 1960’s (see the accompanying background information on Parkinson’s disease for general readers), it is surprising that it was not until four decades later that a major … Continue reading
Posted in Parkinson's Disease
Tagged L-DOPA, Neuroprotection, Parkinson Disease, Rasagiline
Leave a comment